AI fortunes were mixed as premarket trading opened on Wednesday.
SpaceX, Tesla fall around 4% on Democrats' big win; AI stocks mixed
Source: CNBC
Original reporting
CNBC: read the full reportRelated stories
CNBC
What Trump losing power over Congress means for Iran, Ukraine and foreign policy
Democratic control of Congress could bring greater scrutiny of Trump’s handling of the Iran and Ukraine wars, while leaving him broad foreign-policy powers.
CNBC
Euro zone inflation hits 4% for first time in three years as interest rate hike looms
It was driven by energy inflation, which surged above 20% in October.
CNBC
U.S. midterm elections in pictures: Democrats' sweeping victories deliver rebuke to Trump
Democrats scored sweeping victories in the U.S. midterm elections on Wednesday, flipping key Republican-held seats in Congress.
BBC Business
No more rice grains in Kellogg's Rice Krispies due to changing weather
The new recipes mean cereal packaging will now include a 'contains wheat gluten' warning.
The Guardian
Dollar falls while gold and US Treasury bonds rally as markets react to Democrats’ midterm election victory – business live
Democrats’ capture of Congress raise expectations of tougher regulation of AI sector; US stock futures turn positive, reversing earlier declines And Chris Turner , global head of markets at ING, says: Investors will be parsing what this all means. For example, Gina Hinojosa won the Texas governor’s race on a ticket of wanting an immediate moratorium on data centre buildouts. Given AI’s role in powering the US economy, speculation over whether a new Democrat Congress would slow AI capital expenditure plans briefly hit markets. The chip exporter-heavy stock markets of Korea and Taiwan were briefly down 3-4% overnight on news of the blue wave, but have since recouped all those losses. For bond investors, the significance of the midterms is ultimately about what they mean for US borrowing. The result makes further significant fiscal expansion harder to deliver through Congress, potentially e
CNBC
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates